Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.

Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
AAPS PharmSciTech (Impact Factor: 1.78). 02/2006; 7(2):E41. DOI: 10.1208/pt070241
Source: PubMed

ABSTRACT The aim of this study was to evaluate the effect of increasing epinephrine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anaphylaxis. Four tablet formulations, A, B, C, and D, containing 0%, 6%, 12%, and 24% of epinephrine bitartrate, respectively, and microcrystalline cellulose:low-substituted hydroxypropyl cellulose (9:1), were prepared by direct compression, at a range of compression forces. Tablet weight variation, content uniformity, hardness, disintegration time, wetting time, and friability were measured for each formulation at each compression force. All 4 tablet formulations at each compression force were within the United States Pharmacopeia (USP) limits for weight variation and content uniformity. A linear increase in compression force resulted in an exponential increase in hardness for all formulations, a linear increase in disintegration and wetting times of A, and an exponential increase in disintegration and wetting times of B, C, and D. At a mean +/- SD hardness of > or = 2.3 +/- 0.2 kg, all tablet formulations passed the USP friability test. At a mean +/- SD hardness of < or = 3.1 +/- 0.2 kg, all tablet formulations resulted in disintegration and wetting times of <10 seconds and <30 seconds, respectively. Tablets with drug loads from 0% to 24% epinephrine can be formulated with hardness, disintegration times, and wetting times suitable for sublingual administration.

Download full-text


Available from: Mutasem M Rawas-Qalaji, Mar 29, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the present study, Polysaccharide mucilage derived from the seeds of fenugreek, Trigonella foenum-graceum L (family Leguminosae) was investigated as disintegrant for use in mouth dissolving tablet formulations containing metformin hydrochloride. Mucilage extracted from fenugreek seeds were subjected to toxicity studies, it showed that extracted mucilage is devoid of toxicity. Fast disintegrating tablet (FDT) of metformin HCl was formulated using different concentration (2, 4, 6 8 and 10% w/w) of natural disintegrant viz; isolated mucilage of fenugreek seed and synthetic superdisintegrants like croscarmellose sodium and were compared. Disintegration time and drug release were taken as the basis to optimize the rapidly disintegrating tablet. Prepared tablets were evaluated for thickness, hardness, friability, uniformity of weight, disintegration time, wetting time and dissolution study. The formulated tablets had good appearance and better drug release properties as compared to the marketed conventional tablets. Fenugreek mucilage in the concentration of 4 % gives shorter disintegration in 15 sec. and shows 100% drug release within 18 min. is selected as the optimized formulation (F2).Hence, the present study revealed that this natural disintegrant (fenugreek mucilage) showed better disintegrating property than the most widely used synthetic superdisintegrants like Ac-di-sol in the formulations of FDTs. Studies indicated that the extracted mucilage is a good pharmaceutical adjuvant, specifically a disintegrating agent. Optimized formulation was subjected to stability studies as per ICH guidelines at 25
    International Journal of PharmTech Research 10/2009; 1(4).
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epinephrine autoinjectors are underutilized in the first aid emergency treatment of anaphylaxis in the community; so non-invasive sublingual epinephrine administration is being proposed. In order to determine the effect of changing excipients on the bioavailability of sublingual epinephrine, four distinct fast-disintegrating epinephrine 40 mg tablet formulations, A, B, C and D, were manufactured using direct compression. All formulations were evaluated for tablet hardness (H), disintegration time (DT) and wetting time (WT). In a prospective 5-way crossover study, four sublingual formulations and epinephrine 0.3 mg i.m. as a control were tested sequentially in a validated rabbit model. Blood samples were collected before dosing and at intervals afterwards. Epinephrine plasma concentrations were measured using HPLC-EC. All tablet formulations met USP standards for weight variation and content uniformity, and resulted in similar mean H, DT and WT (n=6). The area under the curve (AUC), maximum concentration (C(max)) and time at which C(max) was achieved (T(max)) did not differ significantly after the sublingual administration of formulation A and epinephrine 0.3 mg i.m. The AUC after B, C and D were significantly lower (p<0.05) than after epinephrine 0.3 mg i.m. These results suggest that the selection of excipients used in these tablet formulations can affect the bioavailability of sublingually administered epinephrine.
    Biopharmaceutics & Drug Disposition 12/2006; 27(9):427-35. DOI:10.1002/bdd.519 · 2.18 Impact Factor